Lynne Wagenknecht to Risk
This is a "connection" page, showing publications Lynne Wagenknecht has written about Risk.
Connection Strength
0.327
-
Mirabelli MC, London SJ, Charles LE, Pompeii LA, Wagenknecht LE. Occupation and the prevalence of respiratory health symptoms and conditions: the Atherosclerosis Risk in Communities Study. J Occup Environ Med. 2012 Feb; 54(2):157-65.
Score: 0.095
-
Hughes TM, Wagenknecht LE, Craft S, Mintz A, Heiss G, Palta P, Wong D, Zhou Y, Knopman D, Mosley TH, Gottesman RF. Arterial stiffness and dementia pathology: Atherosclerosis Risk in Communities (ARIC)-PET Study. Neurology. 2018 04 03; 90(14):e1248-e1256.
Score: 0.036
-
Lee CMY, Woodward M, Pandeya N, Adams R, Barrett-Connor E, Boyko EJ, Eliasson M, Franco LJ, Fujimoto WY, Gonzalez C, Howard BV, Jacobs DR, Keinanen-Kiukaanniemi S, Magliano D, Schreiner P, Shaw JE, Stevens J, Taylor A, Tuomilehto J, Wagenknecht L, Huxley RR. Comparison of relationships between four common anthropometric measures and incident diabetes. Diabetes Res Clin Pract. 2017 Oct; 132:36-44.
Score: 0.035
-
Meyer ML, Soliman EZ, Wruck LM, Mosley TH, Wagenknecht LE, Poon AK, Whitsel EA, Alonso A, Heiss G, Loehr LR. Repeatability of ectopic beats from 48-hr ambulatory electrocardiography: The Atherosclerosis Risk in Communities (ARIC) Study. Ann Noninvasive Electrocardiol. 2017 Jul; 22(4).
Score: 0.033
-
Papandonatos GD, Pan Q, Pajewski NM, Delahanty LM, Peter I, Erar B, Ahmad S, Harden M, Chen L, Fontanillas P, Wagenknecht LE, Kahn SE, Wing RR, Jablonski KA, Huggins GS, Knowler WC, Florez JC, McCaffery JM, Franks PW. Genetic Predisposition to Weight Loss and Regain With Lifestyle Intervention: Analyses From the Diabetes Prevention Program and the Look AHEAD Randomized Controlled Trials. Diabetes. 2015 Dec; 64(12):4312-21.
Score: 0.030
-
Howard G, Wagenknecht LE, Kernan WN, Cushman M, Thacker EL, Judd SE, Howard VJ, Kissela BM. Racial differences in the association of insulin resistance with stroke risk: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Stroke. 2014 Aug; 45(8):2257-62.
Score: 0.028
-
Rowe MW, Bergman RN, Wagenknecht LE, Kolberg JA. Performance of a multi-marker diabetes risk score in the Insulin Resistance Atherosclerosis Study (IRAS), a multi-ethnic US cohort. Diabetes Metab Res Rev. 2012 Sep; 28(6):519-26.
Score: 0.025
-
Peter I, McCaffery JM, Kelley-Hedgepeth A, Hakonarson H, Reis S, Wagenknecht LE, Kopin AS, Huggins GS. Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial. Obesity (Silver Spring). 2012 Aug; 20(8):1675-82.
Score: 0.024
-
Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010 Mar 04; 362(9):800-11.
Score: 0.021